Patent · US Active

Drug delivery implants with bi-directional delivery capacity

US11925578B2 · kind B2 · utility

9Cited by

489References

20Claims

0Family size

Assignee

Glaukos Corporation · US

Inventors

Harold A. Heitzmann · Irvine, US
Thomas W. Burns · Dana Point, US
David S. Haffner · Mission Viejo, US

Key dates

Filing date	Sep 1, 2016
Grant date	Mar 12, 2024
Priority date	—
Expiry date	Oct 19, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M31/002
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Certain aspects relate to drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye. In several embodiments, the devices are capable of controlled release of two or more drugs, the release of each drug into a different ocular space (e.g., an ocular compartment versus an ocular fluid outflow pathway).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.